Sensus Healthcare, Inc.
SRTS Healthcare Medical Devices
Sensus Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $27.5 million, down 34.3% from fiscal 2024. In the quarter to June 2026, revenue fell 68.7%, EPS fell 783.3% and free cash flow fell 201.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SRTS
Sensus Healthcare, Inc. (SRTS) P/E ratio
Sensus Healthcare, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 164× (February 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 17.3× | (79.16%) |
| FY2023 | 83.0× | 1,618.85% |
| FY2022 | 4.8× | (83.95%) |
| FY2021 | 30.1× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TELA TELA Bio, Inc. compare | n/m |
| MDAI Spectral AI, Inc. compare | n/m |
| TLIS Talis Biomedical Corporation compare | n/m |
| RPID Rapid Micro Biosystems, Inc. compare | n/m |
| SRTS Sensus Healthcare, Inc. | n/m |
| MYO Myomo, Inc. compare | n/m |
| XTNT Xtant Medical Holdings, Inc. compare | n/m |
| COCH Envoy Medical, Inc. compare | n/m |
| SNWV Sanuwave Health Inc. compare | 3.0× |
| Medical Devices industry median | 23.2× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)